Doxorubicin (DOX)-induced cardiomyopathy (DIC) A study by Fang et al
As a GLP-1 receptor agonist, it acts by mimicking a natural hormone to curb appetite and support sustainable weight loss
Gamma-glutamyl transpeptidase deficiency Disease name Gamma-glutamyl transpeptidase deficiency (OMIM 231950)
One problem with ultra-long-acting injectables is that they are not reversible, and there are certain circumstances in which a patient on a GLP-1 would need to discontinue treatment
Merjaneh, L., He, Q., Long, Q., Phillips, L
Week-by-Week Progress: Your First Month on GLP-1 Week 1: Adjusting to GLP-1 Treatment During the first week, your body starts adapting to the medication